AzTrials
AzTrials

Post-traumatic Stress DisorderTRAUPANCT05268965

Study of Affective Forecasting Skills in Post-traumatic Stress Disorder

An observational study of Post-traumatic Stress Disorder, run by University Hospital, Lille at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Post-traumatic stress disorder (PTSD) is associated with a marked tendency to have exaggerated and persistent negative beliefs and expectations about oneself or the world . Although posttraumatic stress symptoms have been shown to be associated with a tendency to negatively anticipate the future, affective forecasting… Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Post-traumatic Stress Disorder
What is being tested?
Experimental: group comparison
How many people
97 participants
Where
1 siteFrance
Study dates
28 Feb 2022to 22 Nov 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: subjects suffering from post-traumatic stress disorder (PTSD)

Who may be able to join

  • Understanding and being able to express themselves in French
  • Understanding of informed consent and signature of the study participation form
  • Giving informed, dated and signed consent
  • Benefiting from health insurance coverage
  • Normal or corrected visual and auditory acuity to achieve normality
  • Group 1 : DSM-5 PTSD criteria, assessed using CAPS and PTSD Checklist for DSM-5 (PCL-5, Weathers \& al., 2013)
  • Group 2: PTSD Criteria A only

Who cannot join

  • Refusal of participation after clear and fair information on the study.
  • Visual or auditory sensory disability to participate in the study.
  • Personal history of neurological disease or current neurological disease.
  • Personal history of current psychiatric disorder or psychiatric disorder (excluding PTSD in patients in the experimental group), assessed via the MINI.
  • Pregnant or breastfeeding women
  • Consumption of toxic substances other than tobacco and alcohol.
Show all 9Show fewer
  • Minors or adults under guardianship, under judicial protection, persons deprived of liberty.
  • Groups 2 and 3: personal history of psychiatric disorder or current psychiatric disorder and taking psychotropic drugs
  • Group 1: personal history of psychiatric disorders or current psychiatric disorders other than anxiety, depressive, trauma and stress-related disorders and treatment with psychotropic drugs not stabilized

Trial locations and contacts

1 site in 1 country.

France1 site
  • Usn Fontan - Linquette Chu Lille

    Lille

Other trials in France

About this study

Official title: Autonomic and Subjective Correlates of Affective Forecasting Skills in Post-traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) is associated with a marked tendency to have exaggerated and persistent negative beliefs and expectations about oneself or the world . Although posttraumatic stress symptoms have been shown to be associated with a tendency to negatively anticipate the future, affective forecasting skills (i.e., the ability to predict one's own emotional reactions in response to a future event) have never been explored in PTSD . The hypothesis that the PTSD is associated with a negative affective forecasting bias, characterized by a tendency to predict more intense emotional responses to future negative events.

Being tested
Experimental: group comparison
Keywords
Emotion, Post-traumatic stress disorder, Affective forecasting, Virtual reality, Autonomic nervous system, Electrodermal activity
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Experimental: group comparisonBehavioural

    • Standardized psychiatric interview (Mini International Neuropsychiatric Interview MINI)
    • State-Trait-Anxiety Inventory (Spielberger, 1993)
    • Beck Depression Inventory (BDI-II, 1998)
    • Cognitive Emotional Regulation Questionnaire (Jermann \& al., 2006) Participant installation and testing: 2 stages (forecasting on a computer, and exposure in virtual reality)

    Task / affective forecasting:

    • Step 1: forecasting about one's own emotional responses regarding pleasant, neutral and unpleasant scenarios
    • Step 2: experience of the same scenarios in virtual reality
Study groups in NCT05268965
Study groupRoleWhat they receive
Patients meeting DSM-5 criteria for PTSD.Not described
Receives: Behavioral: Experimental: group comparison
Group 2: Healthy controls who experienced a traumatic event but did not meet DSM-5 criteria for PTSDNot described
Receives: Behavioral: Experimental: group comparison
Group 3: Healthy controls who did not experience a traumatic eventNot described
Receives: Behavioral: Experimental: group comparison

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. difference of arousal assessments measured using the Self-Assessment Manikin between the prediction and emotional experience phases

    To compare the subjective affective forecasting bias between the PTSD group and the two control groups

    Measured: During the experimental task (2 hours)

Secondary outcomes (6)
  1. subjective correlates of the affective forecasting bias associated with PTSD changes in: valence scores.

    valence scores using the Self-Assessment Manikin (Likert-type scale ranging from 1 [very unpleasant] to 9 [very pleasant])

    Measured: During the experimental task (2 hours)

  2. autonomic correlates of the affective prediction bias associated with PTSD: changes in the skin conductance response and heart rate.

    changes in the skin conductance response and heart rate assessed using a BIOPAC (System, inc).

    Measured: During the experimental task (2 hours)

  3. link between PTSD symptomatology and affective forecasting bias

    PTSD symptomatology assessed using the Clinician-Administered PTSD Scale (CAPS-5) and PTSD Checklist for DSM-5 (PCL-5)

    Measured: During the experimental task (2 hours)

  4. link and correlation coefficients between biases measured at the neurovegetative (changes in heart rate and skin conductance) and subjective levels (arousal and valence ratings from the Self-Assessment Manikin) in PTSD

    Measured: During the experimental task (2 hours)

  5. link and correlation coefficients between affective forecasting bias and emotion regulation skills within each group

    affective forecasting bias and emotion regulation skills, assessed using the Cognitive Emotional Regulation Questionnaire (CERQ)

    Measured: During the experimental task (2 hours)

  6. link and correlation coefficients between affective forecasting bias and anxiety and depression

    anxiety and depression, respectively assessed using the State-Trait-Anxiety Inventory (STAI) and the Beck Depression Inventory (BDI-II), within each group

    Measured: During the experimental task (2 hours)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2022
  2. Study start28 Feb 2022
  3. Primary completion22 Nov 2023
  4. Study completion22 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
97 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05268965
Sponsor's protocol ID
2021_0385
Other IDs
2021-A01582-39
Acronym
TRAUPA
Status last verified
Dec 2025
First submitted
7 Feb 2022
Last updated
5 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Post-traumatic Stress Disorder, run by University Hospital, Lille at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

difference of arousal assessments measured using the Self-Assessment Manikin between the prediction and emotional experience phases (time frame: During the experimental task (2 hours)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in